Lim Subin, Hong Soon Jun, Kim Ju Hyeon, Cha Jung-Joon, Joo Hyung Joon, Park Jae Hyoung, Yu Cheol Woong, Lim Do-Sun, Nam Chang-Wook
Department of Cardiology, Cardiovascular Center, Korea University Anam Hospital, Korea University College of Medicine, Seoul, Korea.
Division of Cardiology, Department of Internal Medicine, Ewha Womans University Seoul Hospital, Seoul, Korea.
Catheter Cardiovasc Interv. 2025 Aug;106(2):743-751. doi: 10.1002/ccd.31476. Epub 2025 Mar 5.
Diabetes mellitus (DM) is a well-known risk factor for cardiovascular diseases, including coronary artery diseases (CAD). Complex percutaneous coronary intervention (PCI) such as PCI for bifurcation lesions often yields poor outcomes, especially in DM patients.
The effect of DM on cardiovascular outcomes in bifurcation PCI was investigated in this retrospective, multicenter, observational, real-world registry of 2648 patients with coronary bifurcation lesions undergoing PCI with contemporary drug-eluting stents (DES).
The primary outcome was target lesion failure (TLF), defined as a composite of cardiac death, target vessel myocardial infarction and target lesion revascularization. The adjusted outcomes were compared using 1:1 propensity score (PS) matching.
Overall, DM patients were more likely to be older, female, and have hypertension or chronic kidney disease. After PS matching, the cumulative incidence of the primary outcome remained higher in the DM group (7.9% vs. 5.5%, log-rank p = 0.033). In multivariable analysis, DM (HR, 1.57; 95% CI, 1.02-2.43; p = 0.040), chronic kidney disease (HR, 2.62; 95% CI, 1.27-5.38; p = 0.008), low left ventricular ejection fraction (HR, 1.92; 95% CI, 1.10-3.35; p = 0.022) and the two-stent technique (HR, 2.18; 95% CI, 1.17-4.05; p = 0.013) were independent predictors of TLF. For patients with intravascular ultrasound-guided PCI, TLF rates were similar between DM and non-DM groups (9.1% vs. 7.3%, log-rank p = 0.347).
For patients with coronary bifurcation lesions undergoing contemporary PCI, 5-year TLF rates were worse in DM patients. Careful planning and usage of imaging devices may help ameliorate outcomes for DM patients.
糖尿病(DM)是包括冠状动脉疾病(CAD)在内的心血管疾病的一个众所周知的危险因素。复杂的经皮冠状动脉介入治疗(PCI),如分叉病变的PCI,往往效果不佳,尤其是在糖尿病患者中。
在这项回顾性、多中心、观察性、真实世界的注册研究中,对2648例接受当代药物洗脱支架(DES)PCI的冠状动脉分叉病变患者进行了研究,以探讨糖尿病对分叉病变PCI心血管结局的影响。
主要结局为靶病变失败(TLF),定义为心源性死亡、靶血管心肌梗死和靶病变血运重建的复合结局。使用1:1倾向评分(PS)匹配比较调整后的结局。
总体而言,糖尿病患者更可能年龄较大、为女性,且患有高血压或慢性肾脏病。PS匹配后,糖尿病组主要结局的累积发生率仍然较高(7.9%对5.5%,对数秩p = 0.033)。在多变量分析中,糖尿病(HR,1.57;95%CI,1.02 - 2.43;p = 0.040)、慢性肾脏病(HR,2.62;95%CI,1.27 - 5.38;p = 0.008)、低左心室射血分数(HR,1.92;95%CI,1.10 - 3.35;p = 0.022)和双支架技术(HR,2.18;95%CI,1.17 - 4.05;p = 0.013)是TLF的独立预测因素。对于血管内超声引导下PCI的患者,糖尿病组和非糖尿病组的TLF率相似(9.1%对7.3%,对数秩p = 0.347)。
对于接受当代PCI的冠状动脉分叉病变患者,糖尿病患者的5年TLF率更差。仔细规划和使用成像设备可能有助于改善糖尿病患者的结局。